| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 363 | 59.053 | 88.597 | 96.679 | 68.303 | 130.051 | 17.884 | 6.772 | 49.433 | 31.650 |
| Total Income - EUR | 363 | 59.059 | 88.597 | 96.679 | 68.303 | 130.051 | 17.884 | 8.256 | 49.433 | 31.650 |
| Total Expenses - EUR | 429 | 57.831 | 56.566 | 75.440 | 51.994 | 111.092 | 13.143 | 7.883 | 49.355 | 31.589 |
| Gross Profit/Loss - EUR | -66 | 1.228 | 32.032 | 21.239 | 16.309 | 18.959 | 4.741 | 372 | 78 | 61 |
| Net Profit/Loss - EUR | -77 | 568 | 31.170 | 20.272 | 15.626 | 17.658 | 4.204 | 125 | 66 | 51 |
| Employees | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio Ovimar S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.375 | 12.647 | 12.387 | 10.143 | 40.440 | 39.674 | 32.586 | 29.220 | 24.983 | 20.718 |
| Current Assets | 77 | 22.065 | 69.575 | 81.719 | 69.642 | 96.047 | 68.360 | 73.026 | 82.834 | 71.579 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 18.649 | 63.378 | 69.093 | 62.297 | 78.024 | 59.295 | 58.557 | 73.116 | 63.523 |
| Cash | 77 | 3.416 | 6.197 | 12.626 | 7.345 | 18.023 | 9.065 | 14.469 | 9.718 | 8.056 |
| Shareholders Funds | -32 | 536 | 31.697 | 51.387 | 66.018 | 82.425 | 84.801 | 85.189 | 84.996 | 84.573 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.483 | 35.288 | 50.264 | 40.474 | 44.064 | 53.296 | 16.144 | 17.057 | 22.821 | 7.724 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1722 - 1722" | |||||||||
| CAEN Financial Year |
1629
|
|||||||||
Comments - Bio Ovimar S.r.l.